Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)

References

• Baselt RC. Disposition of toxic drugs and chemicals in man. 11th ed. Seal Beach (CA): Biomedical Publications; 2017.
   Google Scholar
• Leikin JBP, Paloucek FP. Poisoning and toxicology handbook. 4th ed. Boca Raton (FL): CRC Press; 2015.
   Google Scholar
• Karch SB, Drummer OH. Karch’s pathology of drug abuse. 5th ed. Boca Raton (FL): CRC Press; 2015.
   Google Scholar
• Liechti ME, Kunz I, Greminger P, et al. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend. 2006;81(3):323–326.
   PubMed Web of Science ®Google Scholar
• Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol. 2012;50(6):458–470.
   PubMed Web of Science ®Google Scholar
• Thai D, Dyer JE, Jacob P, et al. Clinical pharmacology of 1, 4-butanediol and gamma-hydroxybutyrate after oral 1, 4-butanediol administration to healthy volunteers. Clin Pharmacol Ther. 2007;81(2):178–184.
   PubMed Web of Science ®Google Scholar
• Corstens D. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB. J Forensic Leg Med. 2018;54:74–75.
   PubMed Web of Science ®Google Scholar
• Darke S, Lappin J, Farrell M. The clinician’s guide to illicit drugs and health. London: Silverback Publishing; 2019.
   Google Scholar
• Kamal RM, Dijkstra BA, de Weert-van Oene GH, et al. Psychiatric comorbidity, psychological distress, and quality of life in gamma-hydroxybutyrate-dependent patients. J Addict Dis. 2017;36(1):72–79.
   PubMed Web of Science ®Google Scholar
• Brunt TM, Koeter MW, Hertoghs N, et al. Sociodemographic and substance use characteristics of gamma hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. Drug Alcohol Depend. 2013;131(3):316–319.
   PubMed Web of Science ®Google Scholar
• Bennett WM, Wilson LG, Roy-Byrne PP. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report. J Psychoactive Drugs. 2007;39(3):293–296.
   PubMed Web of Science ®Google Scholar
• Abdulrahim D, Bowden-Jones O. Guidance on the management of acute and chronic harms of club drugs and novel psychoactive substances. London: Novel Psychoactive Treatment UK Network (NEPTUNE); 2015.
   Google Scholar
• Corkery JM, Loi B, Claridge H, et al. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use. Neurosci Biobehav Rev. 2015;53:52–78.
   PubMed Web of Science ®Google Scholar
• Caldicott DG, Chow FY, Burns BJ, et al. Fatalities associated with the use of γ-hydroxybutyrate and its analogues in Australasia. Med J Aust. 2004;181(6):310–313.
   PubMed Web of Science ®Google Scholar
• Jones C. Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity. J Clin Forensic Med. 2001;8(2):74–76.
   PubMedGoogle Scholar
• Kintz P, Villain M, Pélissier AL, et al. Unusually high concentrations in a fatal GHB case. J Anal Toxicol. 2005;29(6):582–585.
   PubMed Web of Science ®Google Scholar
• Knudsen K, Greter J, Verdicchio M. High mortality rates among GHB abusers in western Sweden. Clin Toxicol. 2008;46(3):187–192.
   Web of Science ®Google Scholar
• Knudsen K, Jonsson U, Abrahamsson J. Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiol Scand. 2010;54(8):987–992.
   PubMed Web of Science ®Google Scholar
• Kugelberg FC, Holmgren A, Eklund A, et al. Forensic toxicology findings in deaths involving gamma-hydroxybutyrate. Int J Legal Med. 2010;124(1):1–6.
   PubMed Web of Science ®Google Scholar
• Zvosec DL, Smith SW, Porrata T, et al. Case series of 226 gamma-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med. 2011;29(3):319–332.
   PubMed Web of Science ®Google Scholar
• Peck Y, Clough AR, Culshaw PN, et al. Multi-drug cocktails: impurities in commonly used illicit drugs seized by police in Queensland, Australia. Drug Alcohol Depend. 2019;201:49–57.
   PubMed Web of Science ®Google Scholar
• Kintz P, Villain M, Cirimele V, et al. GHB in postmortem toxicology: discrimination between endogenous production from exposure using multiple specimens. Forensic Sci Int. 2004;143(2–3):177–181.
   PubMed Web of Science ®Google Scholar
• Korb AS, Cooper G. Endogenous concentrations of GHB in postmortem blood from deaths unrelated to GHB use. J Anal Toxicol. 2014;38(8):582–588.
   PubMed Web of Science ®Google Scholar
• Kitzman DW, Scholz DG, Hagen PT, et al. Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc. 1988;63(2):137–146.
   PubMed Web of Science ®Google Scholar
• Scholz DG, Kitzman DW, Hagen PT, et al. Age-related changes in normal human hearts during the first 10 decades of life. Part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc. 1988;63(2):126–136.
   PubMed Web of Science ®Google Scholar
• IBM Inc. SPSS for Windows, 25.0. Chicago (IL): SPSS Inc.; 2017.
   Google Scholar
• Darke S, Duflou J. The toxicology of heroin-related death: estimating survival times. Addict. 2016;111(9):1607–1613.
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, Duflou J. Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7 year study. Addict. 2017;112(12):2191–2201.
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Peacock A, et al. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia. Drug Alcohol Depend. 2019;204:107556.
   PubMed Web of Science ®Google Scholar
• Busardò FP, Pichini S. The everlasting issue of GHB cut-offs in biological samples: how important it is to be careful when interpreting values. Forensic Sci Int. 2017;279:e14–e15.
   PubMed Web of Science ®Google Scholar
• Arunogiri S, Moayeri F, Crossin R, et al. Trends in GHB-related harms based on ambulance attendances from 2012–2018 in Victoria, Australia. Addict; 2019. [cited 2020 Feb 6]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/add.14848
   Google Scholar
• Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Educ Prevent Policy. 2012;19(4):320–328.
   Web of Science ®Google Scholar
• McGregor C, Ali R, Christie P, et al. Overdose among heroin users: evaluation of an intervention in South Australia. Addict Res. 2001;9(5):481–501.
   Google Scholar